Zobrazeno 1 - 6
of 6
pro vyhledávání: '"35"'
Publikováno v:
Mediators of Inflammation, Vol 2021 (2021)
Mediators of Inflammation
Mediators of Inflammation
Introduction. Sepsis-induced myocardial dysfunction (SIMD) is the most common complications of sepsis and septic shock with extremely high incidence and mortality. Lipocalin 10 (Lcn10) has recently been identified as a potential biomarker for heart f
Publikováno v:
Mediators of Inflammation, Vol 2020 (2020)
Mediators of Inflammation
Mediators of Inflammation
Objective. The soluble urokinase plasminogen activator receptor (suPAR) is associated with kidney diseases and is used as a prognostic factor of renal function progression. The aim of this study was to explore whether circulating suPAR was associated
Publikováno v:
Disease markers
Disease Markers, Vol 35, Iss 2, Pp 97-103 (2013)
Disease Markers, Vol 35, Iss 2, Pp 97-103 (2013)
Paraoxonase-1 (PON1), a high-density-lipoprotein- (HDL-) associated enzyme, has the potential to protect against atherogenesis. We examine the relationships between plasma PON1 activity and the progression of atherosclerosis as well as coronary arter
Autor:
Wojciech Młynarski, Małgorzata Zubowska, Beata Zalewska-Szewczyk, Wojciech Fendler, Krystyna Wyka
Publikováno v:
Disease Markers
Disease Markers, Vol 35, Iss 6, Pp 811-818 (2013)
Disease Markers, Vol 35, Iss 6, Pp 811-818 (2013)
Novel markers of nephrotoxicity, including kidney injury molecule 1 (KIM-1), interleukin 18 (IL-18), and beta-2 microglobulin, were used in the detection of acute renal injury. The aim of the study was to establish the frequency of postchemotherapy c
Autor:
Bruce W. S. Robinson, Steven J. Skates, Ian M. Dick, Arthur W. Musk, Jenette Creaney, Neil Boudville, Sophie Sneddon, Hanne Dare
Publikováno v:
Disease markers
Disease Markers, Vol 35, Iss 2, Pp 119-127 (2013)
Disease Markers, Vol 35, Iss 2, Pp 119-127 (2013)
TheMSLNgene products, soluble mesothelin and megakaryocyte potentiating factor (MPF), are being investigated as biomarkers for the asbestos-related cancer malignant mesothelioma (MM). Pleural fluid biomarkers of MM can be elevated when serum levels r
Publikováno v:
Canadian Journal of Gastroenterology, Vol 25, Iss 7, Pp 356-357 (2011)
1University of Birmingham Medical School, Birmingham, United Kingdom; 2Department of Pathology, Calgary Laboratory Services; 3Division of Hematology and Hematological Malignancies; 4Liver Unit, Division of Gastroenterology, Department of Medicine, Un